☆ 4.7 Editorial Material

Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer?

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Response-guided long-term treatment of chronic hepatitis D patients with bulevirtide-Results of A real world Study

Mathias Jachs et al.

Summary: Bulevirtide effectively decreases HDV-RNA and ALT levels by blocking the uptake of hepatitis D virus into hepatocytes. The study explores the efficacy and duration of BLV treatment, and proposes a response-guided treatment approach.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Review Gastroenterology & Hepatology

The changing context of hepatitis D

Mario Rizzetto et al.

Summary: The global epidemiology of hepatitis D is changing with the widespread implementation of hepatitis B vaccination. In high-income countries, the epidemiology of chronic hepatitis D is dual, with distinct characteristics observed in endemic countries. Despite recent progress, therapeutic management of HDV remains unsatisfactory.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology